Quantum BioPharma Ltd C.QNTM

Corporate Update!

[Mhae88]

The Company continues to pursue its strategy of completing a Phase 2 clinical trial for the use of its lead compound, ultramicronized-palmitoylethanolamide (or ultramicronized PEA) (“FSD201”), to treat hospitalized COVID-19 patients in a double-blind study (the “Study”).

[Mhae88]

The Company is expected to randomize 352 patients with COVID-19 infection to complete the trial. The Company believes FSD201 to be a safe drug with anti-inflammatory properties which may have the potential to address the over-exuberant inflammatory response characterized by COVID-19 infection that may lead to a cytokine storm and ultimately death. 

[Mhae88]

Due to various factors, primarily relating to challenges with patient recruitment due to active COVID-19 pandemic-related restrictions in hospitals, the Company may not be in a position to complete the Study prior to the end of 2021. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2-Coronavirus) at this

[Mhae88]

The Company currently has a cash balance of approximately C$22 million; the Company expects to require additional financing primarily to initiate another Phase 2 FDA approved study for its lead compound FSD 201 and to effectuate other potential in-licensing and acquisition opportunities. In addition, the Company is actively seeking appropriate potential buyers and is hopeful to finalize the sale

[Renofund]

SHOCKING .... 

[Bigginvestor]

lol oh FSD Pharma when are we going to get our money back never..

[philip1]

you can try getting some from the lawsuit.  I registered last week.  Just google class action fsd pharma ontario. 

[philip1]

They are paying for off shore messaging on this board and others.  Like paying for instagram followers.  Its a couple hundred bucks and they will message on boards.  

[Borat138]

[X] correct